François Delfaud, Chief Executive Officer (PDG), aged 51, founded MEDIT SA during 2003, bringing confirmed skills in software development, molecular modelling, drug design and business development.

From 1997 to 2002, François was account manager in Europe at Accelrys Inc. (Paris, France). From 1994 to 1996, he prepared a thesis in drug design at Synthelabo Recherche (Bagneux, France), now Sanofi-Aventis. François holds a master of Theoritical Chemistry and Informatics and a DESS (University Engineer) in Mass spectra and NMR from Orsay University (France). In 1993, he trained in software development to include anisotropic effect from NOE data at the IGR laboratory (Villejuif, France). In 1992, François studied BPTI interactions with salt by NMR in the ICSN laboratory (Gif-sur-Yvette, France). In 1991, he worked in a IT services company, Trilogie, as a computer engineer.

From 2005 to 2011, François was elected as VP Technology Transfer and SMEs Creation & Development on the board committee of Systematic Paris-Region (French IT competitiveness cluster).

Printable Page
Print this page